|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/18 | |
| A61P 35/00 |
| (11) | Number of the document | 2481415 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11195151.3 |
| Date of filing the European patent application | 2008-02-01 | |
| (97) | Date of publication of the European application | 2012-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 90058007 P | 2007-02-09 | US | |
| 93276207 P | 2007-05-31 | US | |
| 93736507 P | 2007-06-26 | US | |
| 52807 P | 2007-10-25 | US |
| (72) |
Knopf, John, US
Seehra, Jasbir, US
Kumar, Ravindra, US
|
| (73) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | Pharmaceutical compositions comprising Activin-ActRIIA antagonists |
| Pharmaceutical compositions comprising Activin-ActRIIA antagonists |